Logo image of BN.PA

DANONE (BN.PA) Stock Fundamental Analysis

EPA:BN - Euronext Paris - Matif - FR0000120644 - Common Stock - Currency: EUR

71.82  +1.38 (+1.96%)

Fundamental Rating

4

Overall BN gets a fundamental rating of 4 out of 10. We evaluated BN against 58 industry peers in the Food Products industry. There are concerns on the financial health of BN while its profitability can be described as average. BN is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BN had positive earnings in the past year.
In the past year BN had a positive cash flow from operations.
Each year in the past 5 years BN has been profitable.
BN had a positive operating cash flow in each of the past 5 years.
BN.PA Yearly Net Income VS EBIT VS OCF VS FCFBN.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

With a decent Return On Assets value of 4.46%, BN is doing good in the industry, outperforming 62.07% of the companies in the same industry.
Looking at the Return On Equity, with a value of 11.34%, BN is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
BN has a Return On Invested Capital of 6.58%. This is comparable to the rest of the industry: BN outperforms 58.62% of its industry peers.
The Average Return On Invested Capital over the past 3 years for BN is in line with the industry average of 7.10%.
The 3 year average ROIC (6.38%) for BN is below the current ROIC(6.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.46%
ROE 11.34%
ROIC 6.58%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
BN.PA Yearly ROA, ROE, ROICBN.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 7.37%, BN is in the better half of the industry, outperforming 65.52% of the companies in the same industry.
BN's Profit Margin has been stable in the last couple of years.
BN's Operating Margin of 13.00% is fine compared to the rest of the industry. BN outperforms 70.69% of its industry peers.
BN's Operating Margin has declined in the last couple of years.
BN has a better Gross Margin (49.70%) than 79.31% of its industry peers.
BN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 13%
PM (TTM) 7.37%
GM 49.7%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
BN.PA Yearly Profit, Operating, Gross MarginsBN.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BN is still creating some value.
The number of shares outstanding for BN has been increased compared to 1 year ago.
BN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BN has been reduced compared to a year ago.
BN.PA Yearly Shares OutstandingBN.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BN.PA Yearly Total Debt VS Total AssetsBN.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.2 Solvency

An Altman-Z score of 2.43 indicates that BN is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of BN (2.43) is better than 60.34% of its industry peers.
BN has a debt to FCF ratio of 4.89. This is a neutral value as BN would need 4.89 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.89, BN is doing good in the industry, outperforming 68.97% of the companies in the same industry.
A Debt/Equity ratio of 0.66 indicates that BN is somewhat dependend on debt financing.
BN has a worse Debt to Equity ratio (0.66) than 60.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 4.89
Altman-Z 2.43
ROIC/WACC1.05
WACC6.26%
BN.PA Yearly LT Debt VS Equity VS FCFBN.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

A Current Ratio of 0.93 indicates that BN may have some problems paying its short term obligations.
BN has a worse Current ratio (0.93) than 79.31% of its industry peers.
BN has a Quick Ratio of 0.93. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
BN has a Quick ratio of 0.77. This is in the lower half of the industry: BN underperforms 62.07% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.77
BN.PA Yearly Current Assets VS Current LiabilitesBN.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 129.22% over the past year.
BN shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.20% yearly.
The Revenue has decreased by -0.88% in the past year.
Measured over the past years, BN shows a small growth in Revenue. The Revenue has been growing by 1.60% on average per year.
EPS 1Y (TTM)129.22%
EPS 3Y2.12%
EPS 5Y1.2%
EPS Q2Q%472.23%
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%1.24%

3.2 Future

The Earnings Per Share is expected to grow by 6.57% on average over the next years.
The Revenue is expected to grow by 3.75% on average over the next years.
EPS Next Y7.5%
EPS Next 2Y7.65%
EPS Next 3Y7.5%
EPS Next 5Y6.57%
Revenue Next Year4.17%
Revenue Next 2Y3.95%
Revenue Next 3Y3.97%
Revenue Next 5Y3.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BN.PA Yearly Revenue VS EstimatesBN.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10B 20B 30B
BN.PA Yearly EPS VS EstimatesBN.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 22.95, BN is valued on the expensive side.
Based on the Price/Earnings ratio, BN is valued a bit more expensive than the industry average as 63.79% of the companies are valued more cheaply.
The average S&P500 Price/Earnings ratio is at 29.35. BN is valued slightly cheaper when compared to this.
The Price/Forward Earnings ratio is 18.19, which indicates a rather expensive current valuation of BN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BN indicates a slightly more expensive valuation: BN is more expensive than 62.07% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, BN is valued at the same level.
Industry RankSector Rank
PE 22.95
Fwd PE 18.19
BN.PA Price Earnings VS Forward Price EarningsBN.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BN.
BN's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 16.79
EV/EBITDA 10.65
BN.PA Per share dataBN.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BN may justify a higher PE ratio.
PEG (NY)3.06
PEG (5Y)19.11
EPS Next 2Y7.65%
EPS Next 3Y7.5%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.05%, BN has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.37, BN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.33, BN pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.05%

5.2 History

The dividend of BN has a limited annual growth rate of 1.58%.
Dividend Growth(5Y)1.58%
Div Incr Years2
Div Non Decr Years3
BN.PA Yearly Dividends per shareBN.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

66.80% of the earnings are spent on dividend by BN. This is not a sustainable payout ratio.
BN's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP66.8%
EPS Next 2Y7.65%
EPS Next 3Y7.5%
BN.PA Yearly Income VS Free CF VS DividendBN.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
BN.PA Dividend Payout.BN.PA Dividend Payout, showing the Payout Ratio.BN.PA Dividend Payout.PayoutRetained Earnings

DANONE

EPA:BN (3/7/2025, 7:00:00 PM)

71.82

+1.38 (+1.96%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-26 2025-02-26/amc
Earnings (Next)07-29 2025-07-29
Inst Owners54.28%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap48.81B
Analysts72.12
Price Target72.59 (1.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.05%
Yearly Dividend2.1
Dividend Growth(5Y)1.58%
DP66.8%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.83%
PT rev (3m)5.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.2%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.54%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 22.95
Fwd PE 18.19
P/S 1.78
P/FCF 16.79
P/OCF 12.74
P/B 2.74
P/tB N/A
EV/EBITDA 10.65
EPS(TTM)3.13
EY4.36%
EPS(NY)3.95
Fwd EY5.5%
FCF(TTM)4.28
FCFY5.96%
OCF(TTM)5.64
OCFY7.85%
SpS40.29
BVpS26.18
TBVpS-9.15
PEG (NY)3.06
PEG (5Y)19.11
Profitability
Industry RankSector Rank
ROA 4.46%
ROE 11.34%
ROCE 11.27%
ROIC 6.58%
ROICexc 8.06%
ROICexgc 68%
OM 13%
PM (TTM) 7.37%
GM 49.7%
FCFM 10.62%
ROA(3y)2.83%
ROA(5y)3.44%
ROE(3y)7.34%
ROE(5y)9%
ROIC(3y)6.38%
ROIC(5y)6.21%
ROICexc(3y)7.67%
ROICexc(5y)7.39%
ROICexgc(3y)52.44%
ROICexgc(5y)45.6%
ROCE(3y)10.98%
ROCE(5y)10.58%
ROICexcg growth 3Y19.7%
ROICexcg growth 5Y13.36%
ROICexc growth 3Y4.65%
ROICexc growth 5Y1.26%
OM growth 3Y-1.81%
OM growth 5Y-3.08%
PM growth 3Y-1.94%
PM growth 5Y-0.54%
GM growth 3Y1.56%
GM growth 5Y0.26%
F-Score7
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.66
Debt/FCF 4.89
Debt/EBITDA 2.49
Cap/Depr 79.02%
Cap/Sales 3.37%
Interest Coverage 20.69
Cash Conversion 81.04%
Profit Quality 144.05%
Current Ratio 0.93
Quick Ratio 0.77
Altman-Z 2.43
F-Score7
WACC6.26%
ROIC/WACC1.05
Cap/Depr(3y)59.49%
Cap/Depr(5y)65.43%
Cap/Sales(3y)3.2%
Cap/Sales(5y)3.59%
Profit Quality(3y)220.86%
Profit Quality(5y)178.79%
High Growth Momentum
Growth
EPS 1Y (TTM)129.22%
EPS 3Y2.12%
EPS 5Y1.2%
EPS Q2Q%472.23%
EPS Next Y7.5%
EPS Next 2Y7.65%
EPS Next 3Y7.5%
EPS Next 5Y6.57%
Revenue 1Y (TTM)-0.88%
Revenue growth 3Y4.08%
Revenue growth 5Y1.6%
Sales Q2Q%1.24%
Revenue Next Year4.17%
Revenue Next 2Y3.95%
Revenue Next 3Y3.97%
Revenue Next 5Y3.75%
EBIT growth 1Y2.24%
EBIT growth 3Y2.2%
EBIT growth 5Y-1.53%
EBIT Next Year37.33%
EBIT Next 3Y14.67%
EBIT Next 5Y9.76%
FCF growth 1Y11.98%
FCF growth 3Y6.14%
FCF growth 5Y3.12%
OCF growth 1Y11.24%
OCF growth 3Y3.31%
OCF growth 5Y2.15%